Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

NCT00967330 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00967330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma
Lead sponsor
Hoffmann-La Roche
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
September 30, 2014
Enrollment
182 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme